Why Edgewise Therapeutics, Inc. (EWTX) stock rose 9.1% intraday on Thursday, November 5, 2026

Edgewise Therapeutics, Inc. (EWTX) traded at $40.96 as of 1:31 PM ET, up 9.14% on Thursday, November 5, 2026, on volume of 3,085,588 shares (2.2× its 3-month average); market value about $4.40B.

EWTX was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for EWTX on Thursday, November 5, 2026 or the trading day before (November 4, 2026):

• Nov 4, 2026: Reported quarterly results (SEC 8-K) for the quarter ended Sep 30, 2026: EPS $9.65 vs consensus $2.51 (beat), on the analysts' basis (usually adjusted, not GAAP). source
• Nov 5, 2026: Wedbush: Target lowered, Outperform, price target $53 → $51

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on EWTX

EWTX stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 5, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:40 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:40 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt